ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646127 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646127; 2) Community: the network communities that were significantly associated with the response to NSC 646127; 3) Molecule: the relationships between components within communities and NSC 646127; 4) MDR: the compounds that were significantly associated with the NSC 646127.

NSC Compound Enrichment Correlation
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.0459335986102865 -0.074660207
NSC 756251 GW559768X 0.0459335986102865 -0.030238349
NSC 649107 Null 0.0474314077111075 0.27322489
NSC 678106 Rhamnazin 0.0474314077111075 0.037994812
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.048939380959983 -0.15550979
NSC 19441 FDA 0283 0.048939380959983 0.16721312
NSC 526333 2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime 0.048939380959983 -0.076728119
NSC 606869 Clofarabine 0.048939380959983 0.14428037
NSC 627652 Null 0.048939380959983 0.18140611
NSC 627890 Null 0.048939380959983 -0.1472421
Total:78  Current:74    [First] [Prev] [Next] [Last]